PharmPix CEO Dr Martty Martínez Fraticelli wins PBMI Excellence Award for Clinical Innovation

PharmPix President and CEO Dr. Martty Martínez Fraticelli has been honored with the 2026 PBMI Excellence Award for Clinical Innovation by the Pharmacy Benefit Management Institute (PBMI). The recognition underscores Martínez Fraticelli's leadership in advancing a more clinically driven model of pharmacy benefit management.

Martínez Fraticelli's vision is rooted in the belief that a prescription can be processed correctly yet still be inappropriate for the patient. This belief has guided PharmPix since its founding in 2009. The company has integrated clinical intelligence into the pharmacy benefit process, enabling the identification of potential risks, inappropriate therapies, and avoidable costs before they escalate.

"One of our core philosophies is that clinical innovation is about using every tool available to identify what might otherwise be missed, protect members from harm, and ensure the best value for health plans," Martínez Fraticelli explained. "This is what it means to see the whole pharmacy picture."

At the heart of PharmPix's approach is OneArk®, the company's proprietary technology platform. Developed by PharmPix pharmacists and PBM operators, OneArk brings claims adjudication, clinical intelligence, benefit configuration, and real-time decision support together within a single platform. This integration allows PharmPix to continuously build clinical logic directly into the adjudication process, enabling the early detection of potential drug-related issues such as duplicate therapies, inappropriate dosing, and drug interactions.

The platform's capabilities extend across PharmPix's broader clinical strategy, addressing areas such as medication safety, utilization management, specialty pharmacy, biosimilar conversion, formulary oversight, and targeted programs designed to manage emerging clinical and financial risks.

Eric Frontera Zayas, Pharm.D., Senior Vice President of PBM Services at PharmPix, echoed Martínez Fraticelli's sentiment. "Martty has challenged us to think beyond just claim payments. We need to ensure that the therapy is safe, appropriate, and delivers the right value for both the member and the plan. This philosophy has driven our technology and clinical teams."

The award comes as the pharmacy benefit management industry prepares for significant changes. The Consolidated Appropriations Act, 2026, mandates PBMs to disclose more detailed information about pricing, rebates, and plan spending, providing employers and health plans with a more comprehensive view of pharmacy activity. PharmPix sees this as a starting point, emphasizing the importance of turning this visibility into actionable clinical decisions at the moment a prescription is filled.

Martínez Fraticelli will speak at PBMI on September 10 about direct-to-consumer pharmacy models and the emerging questions surrounding clinical responsibility and patient safety.

Founded in 2009, PharmPix is an independent, clinician-led pharmacy benefit manager serving health plans, self-funded employers, government programs, and other PBMs. By leveraging proprietary technology, clinical intelligence, and a consultative approach, PharmPix helps protect members from avoidable harm and plans from avoidable costs, ensuring a comprehensive view of pharmacy benefits.